Calcutta HC Denies Abhishek Banerjee Immediate Relief in DJ Remark Voice Sample Case  ||  Bombay High Court Grants Bombay Group Relief in Vadilal Dispute Against Ahmedabad Group  ||  Kerala HC Orders Time-Bound Disposal of Prisoners' Remission Pleas, Mandates NALSA SOP Compliance  ||  Delhi HC Rejects Plea of Two Army Doctors Seeking NEET PG 2026 Exam Amid Eligibility Rule Challenge  ||  Jharkhand HC: Mother Cannot Consent to a Major Son's DNA Test During a Pending Matrimonial Case  ||  Bombay HC Rules on Whether Arrest is Illegal if Co-Accused Charge Sheet is Not Supplied Earlier  ||  Gujarat HC: State Cannot Indefinitely Reserve Private Land Without Acquisition or Plan Revision  ||  Chhattisgarh HC: Complaints Without Disciplinary Action Cannot Affect a Judge's Seniority  ||  Delhi HC Upholds Selection of India's Dressage Team For the 2026 Asian Games  ||  MP High Court Orders State to Airlift Gas Pipeline Blast Victim to Ahmedabad For Treatment    

Finalization of Draft Rules on Sale of Drugs by E-Pharmacies- (Press Information Bureau) (25 Jun 2019)

MANU/PIBU/0667/2019

Law of Medicine

The Government has published draft rules vide G.S.R. 817 (E) dated 28th August 2018 for inviting public/stakeholder comments for amendment to the Drugs and Cosmetics Rules, 1945 for incorporating provisions relating to regulation of sale and distribution of drugs through e-pharmacy. A large number of suggestions/comments have been received from the stakeholders, which are being examined. At the same time, the matter is sub-judice before various Hon'ble High Courts in the country. Therefore, no timeline for finalization of the rules can be provided.

Under the Drugs & Cosmetics Act and Rules, sale of spurious drugs is a punishable offence and State Licensing Authorities are empowered to take action in this regard. Accordingly, the complaints as received, are referred to State Licensing Authorities for taking action as per the provisions of the Act and Rules.

Tags : DRAFT RULES   FINALIZATION   SALE OF DRUGS   E-PHARMACIES  

Share :        

Disclaimer | Copyright 2026 - All Rights Reserved